Crystal S. Denlinger, MD, FACP of Fox Chase Cancer Center gives an overview of her presentation, which discusses the survivorship…
Browsing: Acute Lymphoblastic Leukemia
Crystal S. Denlinger, MD, FACP of Fox Chase Cancer Center gives an overview of her poster presentation, which was a…
Crystal S. Denlinger, MD, FACP of Fox Chase Cancer Center explains the importance of clinicians speaking about diet, exercise, and…
Becky Lowry, MD of University of Kansas Medical Center gives an overview of her presentation, Survivorship Transitions to Adulthood and…
Becky Lowry, MD of University of Kansas Medical Center discusses the importance of communication between clinicians and survivors during survivorship…
Junne Kamihara, MD, PhD of Dana-Farber Cancer Institute gives an overview of her presentation, TP53 Mutation Carriers: Cancer Genetics in…
Junne Kamihara, MD, PhD of Dana-Farber Cancer Institute explains the significance of the shift from single gene testing to multiplex…
Angela R. Bradbury, MD of Perelman School of Medicine at the University of Pennsylvania discusses the integration of information on…
Angela R. Bradbury, MD of Perelman School of Medicine at the University of Pennsylvania discusses the challenges that came with…
Angela R. Bradbury, MD of Perelman School of Medicine at the University of Pennsylvania gives an overview of the key…
Grant Stewart, MBChB, FRCSEd (Urol), PhD, from the University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK,…
Gerald Mickisch, MD, from the Bremen Center of Operative Urology, Bremen, Germany, discusses how sequential therapy can be used in…
Bertrand Tombal, MD, PhD, Catholic University of Leuven, Leuven, Belgium, discusses the ARASENS trial for prostate cancer at the European…
Anne Kiltie, MD, MRCP(UK), FRCR, from the University of Oxford, Oxford, UK, discusses bladder preservation in muscle invasive bladder cancer…
Morgan Roupret, MD, PhD, from the Pitié-Salpétrière Hospital, Paris, France, discusses what uro-oncologists should know about new drugs in 2017…
Morgan Roupret, MD, PhD, from the Pitié-Salpétrière Hospital, Paris, France, discusses optimization of contemporary bladder cancer care at the European…
Mark Emberton, MD, FRCS Urol, from University College London Hospitals NHS Foundation Trust, London, UK, discusses the potential of intraprostatic…
In this presentation from the 21st Annual Perspectives in Thoracic Oncology, Dr. Philip D. Bonomi discusses new approaches to the…
In this presentation from the 21st Annual Perspectives in Thoracic Oncology, Nurse Beth Eaby-Sandy discusses how to communicate with families…
In this presentation from the 21st Annual Perspectives in Thoracic Oncology, Dr. Vera Hirsh discusses the role of zoledronic acid,…
In this presentation from the 21st Annual Perspectives in Thoracic Oncology, Dr. Corey J. Langer discusses the targeting of angiogenesis…
In this presentation from the 21st Annual Perspectives in Thoracic Oncology, Dr. Ranee Mehra discusses the management of T790-negative EGFR-mutated…
In this presentation from the 21st Annual Perspectives in Thoracic Oncology, Dr. Tracey L. Evans discusses the management of T790-positive…
In this presentation from the 21st Annual Perspectives in Thoracic Oncology, Dr. Vera Hirsh discusses how, when, and where to…
In this presentation from the 21st Annual Perspectives in Thoracic Oncology, Dr. Barbara A. Burtness discusses current and future strategies…
In this presentation from the 21st Annual Perspectives in Thoracic Oncology, Dr. Vassiliki Papadimitrakopoulou discusses the changing face of first-…
In this discussion, the co-chairs of the European Focus on Myeloproliferative Neoplasms & Myelodysplastic Syndromes 2017 highlight the key points…
Gokul Das, PhD of Roswell Park, Department of Pharmacology and Therapeutics describes the effect and consequences of when ER-p53 tumors…
Gokul Das, PhD of Roswell Park, Department of Pharmacology and Therapeutics describes his other study that focuses on the use…
Gokul Das, PhD of Roswell Park, Department of Pharmacology and Therapeutics discusses how to customize therapy based on the stratification…
Gokul Das, PhD of Roswell Park, Department of Pharmacology and Therapeutics gives an overview of his abstract, Novel effect of…
Valerie M. Weaver, PhD of UCSF Medical Center gives an overview of one of her presentations, The Effects of Tumor…
Valerie M. Weaver, PhD of UCSF Medical Center discusses the treatment trends for 2017 in oncology at the American Association…
Valerie M. Weaver, PhD of UCSF Medical Center gives an overview of one of her presentations, Taming the Tumor Microenvironment…
Valerie M. Weaver, PhD of UCSF Medical Center explains the importance in understanding the language of tumors for cancer research…
Valerie M. Weaver, PhD of UCSF Medical Center discusses the research on tumor microenvironment and its impact on cancer research…
Valerie M. Weaver, PhD of UCSF Medical Center explains how the genotype of a tumor affects overall tumor behavior and…
Solange Peters, MD, PhD of Lausanne University Hospital discusses the treatment trends for 2017 which include combination therapy and immunotherapy.…
Solange Peters, MD, PhD of Lausanne University Hospital discusses whether or not there is a correlation between biomarkers, specifically PD-L1…
Solange Peters, MD, PhD of Lausanne University Hospital discusses the impact of Checkmate-026 on current cancer research, stating the data…
Solange Peters, MD, PhD of Lausanne University Hospital gives an overview of her presentation, Impact of tumor mutation burden on…
Kishore Guda, DMV, PhD of Case Western Reserve University discusses the treatment trends for 2017 include immunotherapy and checkpoint inhibitors,…
Athena Matakidou of the Cambridge Cancer Centre discusses Preclinical models of renal cancer at the 12th European International Kidney Cancer…
Henry Withers of Roswell Park Cancer Institute, Department of Genetics gives an overview of his presentation, Characterization of an off-target…
Henry Withers of Roswell Park Cancer Institute, Department of Genetics discusses how the data can predict which patients are at…
Suzanne L. Topalian, MD of Johns Hopkins Kimmel Comprehensive Cancer Center explains where to place immunotherapy in overall treatment plans…
Suzanne L. Topalian, MD of Johns Hopkins Kimmel Comprehensive Cancer Center gives an overview of presentations that were discussed at…
Suzanne L. Topalian, MD of Johns Hopkins Kimmel Comprehensive Cancer Center explains the use of ipilimumab and nivolumab in advanced…
Suzanne L. Topalian, MD of Johns Hopkins Kimmel Comprehensive Cancer Center explains the importance of checkpoint inhibitors, specifically avelumab, in…